Related Experiment Video

Updated: Jun 7, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Disseminated DIG-DIA With a Rare FMR1-RAF1 Fusion With Good Response to Targeted Therapy

Laurence Reeves-Breton1, Laurence Allain1, Sayanthen Sathyakumar2

  • 1Faculty of Medicine, Université Laval, Québec City, Québec, Canada.

Pediatric Blood & Cancer
|November 19, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.0K

Related Experiment Videos

Last Updated: Jun 7, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Conquering Infant and Young Children Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes.

Pediatric blood & cancer·2026

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program.

Pediatric blood & cancer·2026

Impact of Air Bubbles on Cerebrospinal Fluid Drainage in Ventriculoperitoneal Shunts: An Experimental Validation.

Neurosurgery·2026

"Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

Central Nervous System Tumors Among Infants in Canada: A Report From CYP-C.

Pediatric blood & cancer·2026

Quality indicators for the care of children with CNS tumors: An international modified Delphi study.

Neuro-oncology advances·2026

Elevated Blood Lead Levels in Children With Sickle Cell Disease.

Pediatric blood & cancer·2026

Cell-Sorted EBV PCR Identifies Lineage Shift and Guides Management After Hematopoietic Cell Transplantation for Pediatric EBV-Positive T/NK-Cell Lymphoid Neoplasia: A Case Series.

Pediatric blood & cancer·2026

Clinical Characteristics of Intracranial Hemorrhage in Pediatric Acute Leukemia.

Pediatric blood & cancer·2026

Integrating Hereditary Hemorrhagic Telangiectasia into the Diagnostic Workup of Adolescent Heavy Menstrual Bleeding.

Pediatric blood & cancer·2026

Combined Bulk and Single-Cell RNA Sequencing Reveals Alterations in the Immune Microenvironment and Candidate Immune-Related Genes Associated With Diagnosis and Relapse in Childhood B-Cell Acute Lymphoblastic Leukemia.

Pediatric blood & cancer·2026

Gedatolisib after CDK4/6 inhibition in HR-Positive/HER2-negative advanced breast cancer: pharmacology, phase iii evidence, and therapeutic positioning.

Expert opinion on pharmacotherapy·2026

Integrated network toxicology, transcriptomic, and Mendelian randomization analyses explore potential molecular links between acrylamide exposure and clear cell renal cell carcinoma.

Medicine·2026

Completed clinical trials of p53-targeted therapeutic strategies in cancer: A cross-sectional ClinicalTrials.gov registry analysis.

Medicine·2026

PLCG1 regulates pyroptosis to inhibit the progression of non-small cell lung cancer: A Mendelian randomization study.

Medicine·2026

Screening of Modular Self-Assembling Peptides for Targeting the MDM2 Protein.

Journal of peptide science : an official publication of the European Peptide Society·2026

GPR68 Inhibition Induces Ferroptosis in Atypical Teratoid Rhabdoid Tumors.

Cancer reports (Hoboken, N.J.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us